Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-CFB/Complement factor B Antibody (R1H44)

Catalog #:   RHB88502 Specific References (50) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: WB
Accession: P00751
Overview

Catalog No.

RHB88502

Species reactivity

Human

Host species

Rabbit

Isotype

IgG

Clonality

Monoclonal

Tested applications

WB: 1:1000-1:2000

Target

Properdin factor B, Complement factor B, GBG, Glycine-rich beta glycoprotein, BFD, C3/C5 convertase, CFB, PBF2, BF

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P00751

Applications

WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% BSA, 50% Glycerol, 0.05% Sodium azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 4 ℃ for frequent use. Store at -20 ℃ for twelve months from the date of receipt.

Clone ID

R1H44

Data Image
  • Western blot
    Western blot analysis of Complement factor B expression in Human plasma lysate.
References

T-Cell Redirecting Strategies in Large B-Cell Lymphoma and Follicular Lymphoma., PMID:40517438

Assessment of Lyme Seroconversion Among US Military Personnel in Honduras., PMID:40517326

Positive coactivator PC4 shows dynamic nucleolar distribution required for rDNA transcription and protein synthesis., PMID:40517275

Doubling multiplexed imaging capability via spatial expression pattern-guided protein pairing and computational unmixing., PMID:40517167

Modular high-throughput platform for the purification of scFvs and multispecific antibody-based therapeutics., PMID:40516489

Transplants foster B cell alloimmunity by relaying extracellular vesicles to follicular dendritic cells., PMID:40516053

m6A-REFII: an antibody-independent tool for in situ visualizing cellular specific RNA m6A compatible with protein immunofluorescence staining., PMID:40516020

Beyond BCL2 (B cell lymphoma) and BTK (Bruton tyrosine kinase) inhibitors: novel agents and resistance mechanisms for chronic lymphocytic leukemia., PMID:40515863

Response to telitacicept in optic neuritis associated with Sjogren's syndrome: a case report and literature review., PMID:40515854

The Immunology of Alpha-Gal Syndrome: History, Tick Bites, IgE, and Delayed Anaphylaxis to Mammalian Meat., PMID:40515672

A comparison of JC virus assay performance provided with originator and biosimilar natalizumab., PMID:40515643

A Randomized, Double-Blind, 2-Treatment, 2-Period, Crossover Phase 1 Study to Compare the Pharmacokinetics, Safety and Tolerability of 60 IU/Kg of Abcertin and Cerezyme in Healthy Volunteers Following a Single Intravenous Administration., PMID:40515481

First-in-human phase I/II, open-label study of mRNA-2416 alone or combined with durvalumab in patients with advanced solid tumors and ovarian cancer., PMID:40515479

Pooled biomarker analysis of the association of baseline T regulatory cells with response and T-cell recovery profiles with blinatumomab treatment., PMID:40515477

Should We Advance Our Understanding of Immunoglobulin E in Viral Immunity?, PMID:40515421

Anti-melanoma differentiation-associated gene 5 antibody associated rapidly progressive interstitial lung disease in a pediatric patient: a case report., PMID:40514742

Association between rapid and sustained remission and clinician- and patient-reported outcomes in patients with rheumatoid arthritis: post hoc analysis of data from the SELECT-COMPARE study., PMID:40514717

Association of HER2-low with clinicopathological features in patients with early invasive lobular breast cancer: an international multicentric study., PMID:40514709

Multiplex and multimodal mapping of variant effects in secreted proteins via MultiSTEP., PMID:40514537

[Modern systemic treatment-bispecific antibodies and CAR-T cell therapy : Clinical management, mechanisms of action, outcomes]., PMID:40514410

Delphi Survey on Measurable Residual Disease in Multiple Myeloma: Prevailing Practices and the Way Forward in India., PMID:40514308

Anti-CTGF/PD-1 bispecific antibody Y126S restrains desmoplastic and immunosuppressive microenvironment in pancreatic cancer., PMID:40514068

Humoral and cellular immune responses in people living with HIV following successive COVID-19 vaccine booster doses., PMID:40513829

AbEpiTope-1.0: Improved antibody target prediction by use of AlphaFold and inverse folding., PMID:40512857

Structural insights into the activation and inhibition of the ADAM17-iRhom2 complex., PMID:40512800

The dichotomous impacts of Semaphorin3E deficiency on exacerbating airway hyperresponsiveness, remodelling, and inflammation in type-2 low and type-2 high asthma models., PMID:40512736

Characteristics of Two Saccharomyces cerevisiae Strains and Their Extracellular Vesicles as New Candidates for Probiotics., PMID:40512446

Development of a toxin-selective immunotracer for in vivo detection of Clostridioides difficile infection by immunoPET., PMID:40512279

Immune-modulatory effects of Spindlin-1 inhibitors., PMID:40512144

Pharmacokinetics, Receptor Occupancy, and Pharmacodynamics of Obexelimab Following Intravenous Administration in Adult Healthy Volunteers and in Patients With Rheumatoid Arthritis., PMID:40512061

Monoclonal antibody neutralizes Staphylococcus aureus serine protease-like protein B (SplB)-induced pathology., PMID:40512005

Germline-targeting Strategies to Induce bNAbs against HIV-1., PMID:40511646

Children with hepatitis B virus infections, Democratic Republic of the Congo., PMID:40511401

A question of TiME: how microenvironmental interactions shape response to immunotherapy in CLL and Richter Transformation., PMID:40510357

From Molecular Precision to Clinical Practice: A Comprehensive Review of Bispecific and Trispecific Antibodies in Hematologic Malignancies., PMID:40508128

Stromal Hedgehog Signaling Is Associated with Favorable Outcomes in Pancreatic Cancer., PMID:40508010

An Anti-BCMA Affibody Affinity Protein for Therapeutic and Diagnostic Use in Multiple Myeloma., PMID:40507995

Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs., PMID:40507334

B-Cell Epitope Mapping of the Treponema pallidum Tp0435 Immunodominant Lipoprotein for Peptide-Based Syphilis Diagnostics., PMID:40507015

Immune system dynamics in response to Pseudomonas aeruginosa biofilms., PMID:40506442

Corrigendum to "Immobilization of albumin binding domain (ABD) on Sepharose 4B and magnetic particle for efficient single-step purification of human serum albumin" [J. Chromatogr. B 1261 (2025) 124655]., PMID:40506348

Epidemiological insights and clinical management of paediatric kala-azar in Shanxi Province (2014-2023): retrospective analysis of case characteristics and therapeutic strategies., PMID:40506085

Identification of T-cell epitopes of the intracellular parasite Babesia bovis by immunopeptidomic analysis of BoLA-II presented peptides., PMID:40505327

Serological detection of Anaplasma spp., Ehrlichia spp., Borrelia burgdorferi s.l. antibodies, and Dirofilaria immitis antigen in stray dogs in Bosnia and Herzegovina., PMID:40504432

High antigen burden drives CD8+ T cell dysfunction in a mouse model of chronic hepatitis B virus infection., PMID:40503880

Structural and Functional Characterization of Disulfide Bond Isomers of Therapeutic Immunoglobulin G2 Antibody., PMID:40503755

Epitope-driven vaccine design against Listeria monocytogenes: an in-silico approach., PMID:40503559

High-Sensitivity Flow Cytometric Detection of a Small Circulating Population of Nodal T-Follicular Helper Cell Lymphoma Angioimmunoblastic Type Cells., PMID:40503539

T2T-CHM13 versus hg38: accurate identification of immunoglobulin isotypes from scRNA-seq requires a genome reference matched for ancestry., PMID:40503052

Inflammatory arthritis immune related adverse events represent a unique autoimmune disease entity primarily driven by T cells, but likely not autoantibodies., PMID:40502578

Datasheet
$ 290
Product specifications
50 μg 290 100 μg 484

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-CFB/Complement factor B Antibody (R1H44) [RHB88502]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only